To use our some of our online store's time saving features you will need Javascript enabled. You can continue to browse and shop at our store without Javascript but with limited functionality. - Click here to not show this warning again
What are the symptoms?Most people with MVP experience no symptoms. Some may experience difficulty breathing during exertion or when lying down, tremor, fatigue, lightheadedness, dizziness, and fainting. Some develop dull chest pain, palpitations (awareness of the heartbeat), anxiety, and other symptoms associated with the “fight or flight” response. When MVP causes these symptoms, it is referred to as dysautonomia syndrome. Medical optionsThe prescription medications used do not cure mitral valve prolapse, but they can control symptoms associated with the condition. The beta-blockers, such as atenolol (Tenormin®), propranolol (Inderal®), and metoprolol (Lopressor®, Toprol XL®); blood thinners, including aspirin (Bayer Low Adult Strength®, Ecotrin Adult Low Strength®) and warfarin (Coumadin®); and antibiotics to prevent infection and inflammation of the heart’s inner lining may be prescribed. Serious cases might require surgery to repair the affected heart valve. Dietary changes that may be helpfulIn people who have dysautonomia, low salt intake may be part of the problem. Therefore, unless there is another health problem (such as high blood pressure) that is worsened by high salt intake, people with MVP should not restrict the amount of salt in the diet.1 Lifestyle changes that may be helpfulPeople with dysautonomia symptoms should avoid stressful situations and should work on techniques for coping with stress. Vitamins that may be helpfulMagnesium deficiency has been proposed as one cause of the symptoms that occur in association with MVP.2 In a study of people with severe MVP symptoms, blood levels of magnesium were low in 60% of cases. Those people with low magnesium levels participated in a double-blind trial, in which they received a placebo or magnesium (500 mg per day for one week, then about 335 mg per day for four weeks). People receiving magnesium experienced a significant reduction in symptoms of weakness, chest pain, anxiety, shortness of breath, and palpitations.3 In one report, deficient levels of L-carnitine were found in five consecutive people with MVP.4 One of these people was given L-carnitine (1 gram three times per day for four months) and experienced a complete resolution of the symptoms associated with MVP. References (To view, roll mouse over heading; to hide, click on heading) 1. Frederickson L. Confronting Mitral Valve Prolapse Syndrome. New York: Warner Books, 1992. 2. Galland LD, Baker SM, McLellan RK. Magnesium deficiency in the pathogenesis of mitral valve prolapse. Magnesium 1986;5:165–74. 3. Lichodziejewska B, Klos J, Rezler J, et al. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol 1997;79:768–72. 4. Trivellato M, de Palo E, Gatti R, et al. Carnitine deficiency as the possible etiology of idiopathic mitral valve prolapse: case study with speculative annotation. Texas Heart Inst J 1984;11:370–6. Copyright © 2006 Healthnotes, Inc. All rights reserved. www.healthnotes.com Learn more about Healthnotes, the company. Learn more about the authors of Healthnotes. The information presented in Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or chemist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires March 2007.
|
©CopyRight 2004-2006 - All Rights Reserved - Authentic Produce Limited
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||